KPIs & Operating Metrics(New)
Growth Metrics

Bristol Myers Squibb (BMY) Acquisitions (2016 - 2026)

Bristol Myers Squibb has reported Acquisitions over the past 16 years, most recently at $65.0 million for Q1 2026.

  • Quarterly Acquisitions fell 16.67% to $65.0 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $3.9 billion through Mar 2026, up 112.95% year-over-year, with the annual reading at $3.9 billion for FY2025, 81.93% down from the prior year.
  • Acquisitions was $65.0 million for Q1 2026 at Bristol Myers Squibb, down from $1.7 billion in the prior quarter.
  • Over five years, Acquisitions peaked at $20.1 billion in Q1 2024 and troughed at $47.0 million in Q4 2024.
  • The 5-year median for Acquisitions is $348.0 million (2024), against an average of $1.8 billion.
  • Year-over-year, Acquisitions skyrocketed 25608.97% in 2024 and then crashed 99.61% in 2025.
  • A 5-year view of Acquisitions shows it stood at $116.0 million in 2022, then skyrocketed by 400.86% to $581.0 million in 2023, then crashed by 91.91% to $47.0 million in 2024, then skyrocketed by 3531.91% to $1.7 billion in 2025, then plummeted by 96.19% to $65.0 million in 2026.
  • Per Business Quant, the three most recent readings for BMY's Acquisitions are $65.0 million (Q1 2026), $1.7 billion (Q4 2025), and $1.9 billion (Q3 2025).